Even though the stock has become cheaper, we don't have much confidence in Incyte. Here are three reasons why there are better opportunities than INCY and a stock we'd rather own. Founded in 1991 and ...

Mad Square Review: The Telugu film Mad Square starring Narne Nithiin, Sangeeth Shobhan, and Ram Nithiin, hits the theatres today, March 28. It is the sequel to the 2023 film MAD. The story ...

Her expertise is in personal finance and investing, and real estate. Morsa Images / Getty Images Sequence risk is the danger that the timing of withdrawals from a retirement account will have a ...

Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis ...

On Wednesday, RBC Capital adjusted its outlook on CrowdStrike Holdings (NASDAQ:CRWD), increasing the price target to $420 from the ...

Incyte Corp (NASDAQ:INCY) stock is down 11.4% to trade at $60.16 at last glance, after the pharmaceutical company's phase three trial data for its skin disease treatment showed it was only ...

Incyte Corporation (INCY), headquartered in Wilmington, Delaware, discovers, develops, and commercializes therapeutics for hematology/oncology, as well as inflammation and autoimmunity areas.